Oter anti-inflammatory and antirheumatic agents, non-steroids

PheWeb

RX_NSAID_OTHER

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC M01AX

73243

Check pre-conditions, main-only, mode, ICD version None

25684

Check minimum number of events

Min. number of events 3

25684

Include endpoints None

25684

RX_NSAID_OTHER

Extra metadata

First used in FinnGen datafreeze DF4

Similar endpoints

↥

List of similar endpoints to Oter anti-inflammatory and antirheumatic agents, non-steroids based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Glucosamine medication

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	25028	17130	7898
Unadjusted prevalence (%)	8.11	9.87	5.85
Mean age at first event (years)	55.63	55.09	56.82

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.01	0.91 [0.81, 1.03]	1.3e-1	2421
15 years	0.01	0.82 [0.73, 0.92]	7.0e-4	1539
5 years	0.00	0.82 [0.71, 0.94]	3.5e-3	333
1 year	0.00	0.72 [0.53, 0.97]	2.9e-2	51

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_NSAID_OTHER – Oter anti-inflammatory and antirheumatic agents, non-steroids
GWS hits:

Survival analyses between endpoints

↥

Plot

before Oter anti-inflammatory and antirheumatic agents, non-steroids
after Oter anti-inflammatory and antirheumatic agents, non-steroids

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Oter anti-inflammatory and antirheumatic agents, non-steroids

↥